slides · global inventory
Title
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 303,780
Current window 33,571-33,600
Pages 10,126
Rows per page 30
Component
33,571-33,600 of 303,780
27
The table uses a green/white color coding to highlight the superior profile of NVL-655 compared to existing therapies.Nuvalent | IPO Presentation Deck | 40 slides · Nuvalent
Pitch deck Investment bank Loop · Cost Of Inaction2 hits
28
The slide uses a structured table format to define the product's key performance characteristics.Nuvalent | IPO Presentation Deck | 40 slides · Nuvalent
Pitch deck Investment bank 2 hits
31
The chart uses a logarithmic scale to show fold-selectivity. NVL-655 shows significantly higher selectivity for ALK variants compared to the other two drugs.Nuvalent | IPO Presentation Deck | 40 slides · Nuvalent
Pitch deck Investment bank 2 hits
33
Includes disclaimer regarding clinical studies and FDA feedback.Nuvalent | IPO Presentation Deck | 40 slides · Nuvalent
Pitch deck Investment bank 2 hits
35
The slide uses a hexagonal process flow diagram to illustrate the three-step methodology.Nuvalent | IPO Presentation Deck | 40 slides · Nuvalent
Pitch deck Investment bank 2 hits
38
The slide uses a dual-track timeline: top for corporate events, bottom for clinical/R&D pipeline progress.Nuvalent | IPO Presentation Deck | 40 slides · Nuvalent
Pitch deck Investment bank 2 hits
01
Omega Therapeutics | IPO Presentation Deck | 33 slidesOmega Therapeutics | IPO Presentation Deck | 33 slides · Omega Therapeutics
Pitch deck Investment bank 2 hits
07
The slide uses a four-column layout to define the platform's technological pillars.Omega Therapeutics | IPO Presentation Deck | 33 slides · Omega Therapeutics
Pitch deck Investment bank 2 hits
09
The slide uses a biological diagram to illustrate the interaction between the OEC protein complex and the DNA structure.Omega Therapeutics | IPO Presentation Deck | 33 slides · Omega Therapeutics
Pitch deck Investment bank 2 hits
10
The slide uses a process flow diagram to show the transition from a diseased state to a restored state via OEC intervention.Omega Therapeutics | IPO Presentation Deck | 33 slides · Omega Therapeutics
Pitch deck Investment bank 2 hits
17
The chart shows a log-scale significance plot across chromosomes 1-22, highlighting a single outlier point.Omega Therapeutics | IPO Presentation Deck | 33 slides · Omega Therapeutics
Pitch deck Investment bank 2 hits
18
The slide uses three distinct charts to show tunability (bar chart) and durability (two line charts over time).Omega Therapeutics | IPO Presentation Deck | 33 slides · Omega Therapeutics
Pitch deck Investment bank 2 hits
19
Shows mechanism of action: OEC targets EpiZip -> downregulates MYC -> apoptosis in cancer cells, but not in normal cells.Omega Therapeutics | IPO Presentation Deck | 33 slides · Omega Therapeutics
Pitch deck Investment bank 2 hits
20
The slide presents two line charts: one for tumor volume and one for body weight change, demonstrating efficacy and safety/tolerability.Omega Therapeutics | IPO Presentation Deck | 33 slides · Omega Therapeutics
Pitch deck Investment bank 2 hits
21
The slide compares tumor luminescence (growth) and body weight change (toxicity) across three groups: negative control, OEC candidate, and Sorafenib.Omega Therapeutics | IPO Presentation Deck | 33 slides · Omega Therapeutics
Pitch deck Investment bank 2 hits
22
The slide uses visual evidence (microscopy images) to demonstrate the mechanism of action (MoA) of the OEC candidate.Omega Therapeutics | IPO Presentation Deck | 33 slides · Omega Therapeutics
Pitch deck Investment bank 2 hits
23
The slide presents two line charts: one for tumor volume (efficacy) and one for body weight change (safety/toxicity).Omega Therapeutics | IPO Presentation Deck | 33 slides · Omega Therapeutics
Pitch deck Investment bank 2 hits
24
Histology images (H&E staining) demonstrate therapeutic efficacy of OEC candidate.Omega Therapeutics | IPO Presentation Deck | 33 slides · Omega Therapeutics
Pitch deck Investment bank 2 hits
25
The slide demonstrates cross-species efficacy of the OEC candidate in vivo.Omega Therapeutics | IPO Presentation Deck | 33 slides · Omega Therapeutics
Pitch deck Investment bank 2 hits
26
The chart uses a box plot to compare four groups: Normal, Disease control, Dexamethasone, and OEC. The OEC group shows a statistically significant reduction.Omega Therapeutics | IPO Presentation Deck | 33 slides · Omega Therapeutics
Pitch deck Investment bank 2 hits
27
The chart demonstrates that the therapeutic intervention successfully crosses the therapeutic threshold, suggesting potential for hair growth enhancement.Omega Therapeutics | IPO Presentation Deck | 33 slides · Omega Therapeutics
Pitch deck Investment bank 2 hits
33
The slide uses a hub-and-spoke diagram to map specific delivery sites (brain, lung, liver, joint, tumors) to corresponding imaging results.Omega Therapeutics | IPO Presentation Deck | 33 slides · Omega Therapeutics
Pitch deck Investment bank 2 hits
01
Includes SEC filing disclaimer in top right corner.Orange County Bancorp | IPO Presentation Deck | 28 slides · Orange County Bancorp
Pitch deck Investment bank 2 hits
04
Orange County Bancorp | IPO Presentation Deck | 28 slidesOrange County Bancorp | IPO Presentation Deck | 28 slides · Orange County Bancorp
Pitch deck Investment bank 2 hits
06
Includes a map of branch locations and a structured table of financial KPIs categorized by profitability, capital, and asset quality.Orange County Bancorp | IPO Presentation Deck | 28 slides · Orange County Bancorp
Pitch deck Investment bank Beat · Problem2 hits
07
The slide uses a matrix-like structure to compare three business units across two dimensions: Structure & Scope and Key Metrics.Orange County Bancorp | IPO Presentation Deck | 28 slides · Orange County Bancorp
Pitch deck Investment bank Beat · Solution2 hits
13
The slide uses CAGR trend lines to emphasize consistent growth across key financial metrics.Orange County Bancorp | IPO Presentation Deck | 28 slides · Orange County Bancorp
Pitch deck Investment bank Loop · Hypothesis Test2 hits
15
The slide compares OBT performance against local peers and breaks down revenue streams.Orange County Bancorp | IPO Presentation Deck | 28 slides · Orange County Bancorp
Pitch deck Investment bank 2 hits
16
Includes data on NPAs, Net Charge-offs, and Yield on Loans from 2018 to 2021 Q1.Orange County Bancorp | IPO Presentation Deck | 28 slides · Orange County Bancorp
Pitch deck Investment bank Beat · Financials2 hits
01
Pathward Financial | Results Presentation Deck | 27 slidesPathward Financial | Results Presentation Deck | 27 slides · Meta Financial Group
Conference presentation Investor relations 2 hits